Literature DB >> 33331279

Successful treatment with photodynamic therapy in a patient with nasal mucocutaneous leishmaniasis undergoing treatment with TNFα inhibitor.

Paulina A Cerro1, Milagros Sánchez-Hernández1, Ana María Morales-Callaghan1, Natalia Estrada-Mallarino2, Yolanda Gilaberte1.   

Abstract

Entities:  

Year:  2020        PMID： 33331279      PMCID： PMC7880660          DOI： 10.1684/ejd.2020.3921

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  10 in total

Review 1.  Leishmaniasis.

Authors:  Esther Von Stebut
Journal:  J Dtsch Dermatol Ges       Date:  2015-03       Impact factor: 5.584

2.  Leishmania tropica successfully treated with photodynamic therapy.

Authors:  Dana R-Ml Slape; Emma N-Y Kim; Paul Weller; Monisha Gupta
Journal:  Australas J Dermatol       Date:  2018-06-22       Impact factor: 2.875

3.  Photodynamic Therapy in the Treatment of Cutaneous Leishmaniasis.

Authors:  L Sainz-Gaspar; E Rosón; J Llovo; H Vázquez-Veiga
Journal:  Actas Dermosifiliogr (Engl Ed)       Date:  2018-06-28

4.  Effective treatment of cutaneous leishmaniasis caused by Leishmania tropica with topical photodynamic therapy.

Authors:  Christine Fink; Ferdinand Toberer; Alexander Enk; Patrick Gholam
Journal:  J Dtsch Dermatol Ges       Date:  2016-08       Impact factor: 5.584

Review 5.  Antimicrobial effects of photodynamic therapy.

Authors:  Vanesa Pérez-Laguna; Ana J García-Malinis; Carmen Aspiroz; Antonio Rezusta; Yolanda Gilaberte
Journal:  G Ital Dermatol Venereol       Date:  2018-04-19       Impact factor: 2.011

6.  European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 2: emerging indications - field cancerization, photorejuvenation and inflammatory/infective dermatoses.

Authors:  C A Morton; R-M Szeimies; N Basset-Séguin; P G Calzavara-Pinton; Y Gilaberte; M Haedersdal; G F L Hofbauer; R E Hunger; S Karrer; S Piaserico; C Ulrich; A-M Wennberg; L R Braathen
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-12-05       Impact factor: 6.166

7.  Analysis of Macrophage Activation Markers in an Experimental Model of Cutaneous Leishmaniasis Treated with Photodynamic Therapy Mediated by 5-Aminolevulinic Acid.

Authors:  Mona Lisa Fabiana Silva; Polyanna Miranda Alves; Danila Malheiros Souza; Marcos Vinicius Silva; João Paulo Dos Santos; Tony de Paiva Paulino; Denise Bertulucci Rodrigues; Virmondes Rodrigues
Journal:  Photobiomodul Photomed Laser Surg       Date:  2019-04-12

8.  Effective treatment with photodynamic therapy of cutaneous leishmaniasis: A case report.

Authors:  Mila Broby Johansen; Gregor B E Jemec; Susanne Fabricius
Journal:  Dermatol Ther       Date:  2019-07-28       Impact factor: 2.851

9.  Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells.

Authors:  Oleg E Akilov; Sachiko Kosaka; Katie O'Riordan; Tayyaba Hasan
Journal:  Exp Dermatol       Date:  2007-08       Impact factor: 3.960

10.  Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression.

Authors:  Pau Bosch-Nicolau; Maria Ubals; Fernando Salvador; Adrián Sánchez-Montalvá; Gloria Aparicio; Alba Erra; Pablo Martinez de Salazar; Elena Sulleiro; Israel Molina
Journal:  PLoS Negl Trop Dis       Date:  2019-08-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.